MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ERWIN, V. G.
Right arrow Articles by BRONAUGH, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ERWIN, V. G.
Right arrow Articles by BRONAUGH, R. L.

Molecular Pharmacology, Vol 7, 169-176, Copyright © 1971 by the American Society for Pharmacology and Experimental Therapeutics

Inhibition of a Reduced Nicotinamide Adenine Dinucleotide Phosphate-Linked Aldehyde Reductase from Bovine Brain by Barbiturates

V. GENE ERWIN 1, B. TABAKOFF 1, and ROBERT L. BRONAUGH 1

1 School of Pharmacy, University of Colorado, Boulder, Colorado 80302

The partially purified NADPH-linked aldehyde reductase (alcohol:NADP oxidoreductase, EC 1.1.1.2) from bovine brain has been further characterized, and inhibition of the enzyme by barbiturates has been investigated. In addition to substituted benzaldehydes and phenylethanols, free indoleacetaldehyde was observed to be a substrate for the enzyme. In the present studies, it was found that brain aldehyde reductase is markedly inhibited by barbital, phenobarbital, pentobarbital, and amobarbital, with Ki values ranging from 50 to 400 µM. Inhibition by these agents was reversible and of a noncompetitive type with respect to p-nitrobenzaldehyde, indoleacetaldehyde, p-hydroxyphenylglycolaldehyde, or NADPH. The enzyme was not markedly inhibited by amobarbital alcohol, a normal metabolite of amobarbital, or by barbituric acid; Ki values for these compounds were found to be 0.6 and 4 mM, respectively. Evidence is presensted suggesting that inhibition of aldehyde reductase by the barbiturates is due to the ionized form of the inhibitors. Pyrazole, a potent inhibitor of alcohol dehydrogenase, did not inhibit aldehyde reductase, and the barbiturates had no effect on alcohol dehydrogenase. The differential sensitivity of aldehyde reductase to the inhibitory effects of barbiturates and pyrazole is used to distinguish this enzyme from liver alcohol dehydrogenase.

Submitted on December 5, 1970







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1971 by the American Society for Pharmacology and Experimental Therapeutics